p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis  by Vaseva, Angelina V. et al.
p53 Opens the Mitochondrial
Permeability Transition Pore
to Trigger Necrosis
Angelina V. Vaseva,1 Natalie D. Marchenko,1 Kyungmin Ji,2 Stella E. Tsirka,2 Sonja Holzmann,3 and Ute M. Moll1,3,*
1Department of Pathology
2Deparatment Pharmacology
Stony Brook University, Stony Brook, NY 11794, USA
3Department of Molecular Oncology, University of Go¨ttingen, 37077 Go¨ttingen, Germany
*Correspondence: ute.moll@sbumed.org
DOI 10.1016/j.cell.2012.05.014SUMMARY
Ischemia-associated oxidative damage leading to
necrosis is a major cause of catastrophic tissue
loss, and elucidating its signaling mechanism is
therefore of paramount importance. p53 is a central
stress sensor responding to multiple insults, in-
cluding oxidative stress to orchestrate apoptotic
and autophagic cell death. Whether p53 can also
activate oxidative stress-induced necrosis is,
however, unknown. Here, we uncover a role for
p53 in activating necrosis. In response to oxidative
stress, p53 accumulates in the mitochondrial matrix
and triggers mitochondrial permeability transition
pore (PTP) opening and necrosis by physical inter-
action with the PTP regulator cyclophilin D (CypD).
Intriguingly, a robust p53-CypD complex forms
during brain ischemia/reperfusion injury. In contrast,
reduction of p53 levels or cyclosporine A pretreat-
ment of mice prevents this complex and is associ-
ated with effective stroke protection. Our study
identifies the mitochondrial p53-CypD axis as an
important contributor to oxidative stress-induced
necrosis and implicates this axis in stroke pathology.
INTRODUCTION
Three morphologically distinct types of cell death occur in phys-
iologic and pathologic processes: apoptosis, autophagy, and
necrosis (Edinger and Thompson, 2004). p53 is a critical tran-
scriptional activator and exerts additional biochemical functions
in the cytoplasm. In its central role as cellular stress sensor that
responds to a myriad of signals including DNA damage, oxida-
tive stress and ischemia, p53 controls programs of apoptosis
via transcription-dependent and -independent mechanisms
to limit the propagation of damaged cells. p53-controlled
apoptosis involves transcriptional induction of components of
the death receptor and mitochondrial pathways including
CD95, Puma, Noxa, Bax, and others, which cooperatively1536 Cell 149, 1536–1548, June 22, 2012 ª2012 Elsevier Inc.promote cell death (Brady et al., 2011; Riley et al., 2008). In addi-
tion, p53 protein can directly promote mitochondrial outer
membrane permeabilization (MOMP) to trigger apoptosis by
modulating the MOMP governing Bcl-2 family (Green and
Kroemer, 2009; Vaseva and Moll, 2009). We and others previ-
ously identified a p53 protein-based mitochondrial apoptosis
program. Upon stress, a cytoplasmic pool of p53 rapidly translo-
cates to the mitochondrial surface, where it physically interacts
with both anti- and proapoptotic Bcl-2 family members to inhibit
or activate their respective functions, leading to MOMP and
apoptosis. In this role, p53 acts like a BH3-only protein, either
as direct activator of the Bax/Bak effectors, or as sensitizer/
derepressor of Bcl-xL/2 andMcl1 (Vaseva andMoll, 2009). While
in principle the proapoptotic effects of cytoplasmic p53 are not
dependent on transcription by nuclear p53, the latter appears
to enhance the function of cytoplasmic p53.
p53 also has a complex role in regulating autophagywhich can
promote either cell survival under stress or cell death, dependent
on context. Activated nuclear p53 can transcriptionally induce
AMPK and sestrin1/2 with subsequent mTOR inhibition and
autophagy. Autophagy can promote cell death when apoptosis
is compromised, or act as reinforcement of apoptotic caspase
signaling. The overlap between apoptosis and autophagy in
p53-activated cell death is illustrated by the p53 target genes
DRAM, Bax, and Puma, also shown to be positive autophagy
regulators. Conversely, basal levels of p53 in the cytoplasm
can directly inhibit autophagosomes (Vousden and Ryan, 2009).
Necrosis is the irreversible tissue destruction due to bioener-
getic failure, and central to ischemia/reperfusion injury and
oxidative damage as occurs in cerebral stroke and myocardial
infarction. The fundamental difference to apoptosis is the rapid
loss of cellular membrane potentials due to energy deple-
tion and ion pump/channel failures, leading to swelling, rupture,
and cytolysis. Mediators of necrosis are excess cytosolic Ca2+
and ROS levels. Rather than being a passive event, necrosis
has emerged as a controlled cell death that induces an in-
flammatory response to stimulate tissue repair by selectively
releasing factors like HMGB1 and HDGF from dying cells
(Zong and Thompson, 2006). Necrosis in ischemic tissues, which
is experimentally modeled by H2O2 treatment of cultured cells,
depends on cyclophilin D (CypD), the key regulator of the
mitochondrial permeability transition pore (PTP) at the inner
membrane whose opening leads to cell death (Halestrap,
2006). As shown by four independent strains, CypD/ mice
are resistant to ischemia-induced necrosis in myocardial infarc-
tion and stroke, and CypD-deficient mitochondria and cells are
resistant to Ca2+ and H2O2-induced cell death. But notably,
they remain sensitive to Bcl-2 family-driven apoptosis, empha-
sizing the two functionally distinct mitochondrial death systems
(Baines et al., 2005; Basso et al., 2005; Nakagawa et al., 2005;
Schinzel et al., 2005). PTP is a regulated nonselective water-
and solute-passing protein channel spanning the inner (IMM)
and outer (OMM) mitochondrial membranes at points of contact.
The identity of the actual pore-forming proteins of PTP are still
debated, since they appear in part dispensable (Baines, 2010)
but can encompass VDAC (voltage-dependent anion channel)
across the OMM, and ANT (adenine nucleotide translocase)
across the IMM. In contrast, the prolyl isomerase CypD in the
mitochondrial matrix is the essential regulator of the PTP pore
opening, and the only genetically proven indispensable PTP
component (Kroemer et al., 2007).
H+ pumping out of thematrix creates the proton gradientDJm
across the IMM necessary to maintain mitochondrial respiration
and ATP production. In unstressed cells, PTP is closed and the
IMM impermeable to ions. Upon oxidative stress, sudden PTP
opening causes massive ion influx that dissipates DJm and
shuts down oxidative phosphorylation and ATP production.
This is called mitochondrial permeability transition (mPT).
Concomitantly, water influx causes matrix swelling, rupture of
the rigid OMM and release of all sequestered cell death factors.
mPT is triggered by mitochondrial matrix sequestration of high
levels of cytosolic Ca2+ and ROS generated during oxidative
damage. Clinically, CypD-triggered PTP opening and mPT is
the driving pathophysiological force behind cerebral stroke,
myocardial infarction and other vascular catastrophies that are
leading causes of death. How CypD becomes activated to
inducemPT remains unclear but depends on its prolyl isomerase
activity. Cyclosporine A (CsA) potently and specifically prevents
mPT by binding to CypD, inhibiting its isomerase activity and dis-
placing it from the PTP (Kroemer et al., 2007).
It is currently unknownwhether p53 can also activate oxidative
stress-induced necrosis. Intriguingly, our findings provide
genetic, biochemical and pharmacological evidence that funda-
mentally expands our understanding of p53-mediated cell death
networks into necrosis. We identify an unexpected critical role of
stress-accumulated mitochondrial p53 protein in directly regu-
lating PTP at the inner membrane. Upon oxidative stress, p53
triggers PTP opening by engaging in a physical interaction with
CypD, thereby inducing necrotic cell death in mouse and human
cells. Importantly, this pathway is implicated in brain ischemia-
reperfusion injury.
RESULTS
In Addition to Bax/Bak Lipid Pores, Purified p53 Also
Engages PTP to Induce Mitochondrial Membrane
Permeabilization
We previously showed in isolated mitochondria that purified p53
causes robust cytochrome C (CytoC) release by inducing Bakoligomerization and MOMP with the same efficiency as tBid
(Mihara et al., 2003; Wolff et al., 2008). Moreover, we showed
that p53 is able to release the entire gamut of soluble and nonsol-
uble apoptogenic factors including noncleaved apoptosis-
inducing factor (AIF) and Endo G that are tethered to the IMM
by severely disrupting both outer and inner mitochondrial
membrane integrity. In contrast, tBid is restricted to releasing
only soluble components via MOMP (Wolff et al., 2008). This
suggests a stronger permeabilizing effect by p53 than by the
prototypical activator of the Bax/Bak pore, tBid. Thus, we
hypothesized that p53 is capable of recruiting additional BH3-
independent pathways of mitochondrial permeabilization.
To this end, we compared the release response of isolatedWT
and Bax/Bak double-knockout (DKO) mitochondria (Figure S1A
available online) toward highly purified recombinant p53 and
tBid. Bax/Bak DKO cells are deprived of the apoptotic gateway
to mediate CytoC release for caspase activation (Kim et al.,
2006). Indeed, p53 was able to rapidly release CytoC, Smac
(soluble), and AIF (membrane tethered) from both WT and Bax/
Bak DKO mitochondria, while the tBid-induced release was
restricted to WT mitochondria (Figure 1A). The strict Bax/Bak-
dependence of tBid-mediated MOMP is completely consistent
with the notion of tBid as direct activator of the Bax/Bak lipid
pore, tBid’s sole target (Kuwana et al., 2005). In contrast, p53
apparently has additional mitochondrial targets to mediate
mitochondrial permeabilization.
We reasoned that p53 might also engage the mitochondrial
PTP pore. To look for evidence of p53-induced functional alter-
ations of this pore, we used the fluorescent dye calcein, a highly
selective indicator of sustained PTP opening in situ (Kroemer
et al., 2007). MOMP and the Bax/Bak lipid pore are completely
incompetent for calcein release (Petronilli et al., 1998). Adding
increasing doses of purified p53 to calcein-prelabeled WT or
Bax/Bak DKO mitochondria resulted in a rapid and almost
complete loss of signal, indicating PTP opening. In contrast,
even the highest dose of tBid lacked any effect (Figure 1B and
Figure S1B). Moreover, p53 but not tBid induced structural alter-
ations of PTP components. WT mouse liver mitochondria were
incubated with increasing amounts of purified p53 prior to
chemical crosslinking. VDAC-containing complexes ranging
from60–300 kDawere readily detected in control mitochondria
incubated with buffer or BSA but increasingly disappeared upon
addition of p53 in a dose-dependent fashion (Figure 1C and Fig-
ure S1C). Thus, p53 was able to drive VDAC into high molecular
weight complexes that no longer entered the gel. This activity
was unique to p53, since tBid had no effect on VDAC oligomer-
ization (Figure 1D). Moreover, p53 but not tBid was able
to induce swelling (another classical hallmark of PTP opening)
of Bax/Bak DKO and WT mitochondria in a CsA-dependent
(Figure 1E) and CypD-dependent (Figures 1F and 1G) manner.
Thus, in addition to the Bax/Bak lipid pore, p53 can also
engage the PTP pore to induce mitochondrial membrane
permeabilization.
p53 Protein Interacts with the Essential Regulatory PTP
Component CypD
Based on these results, we next asked whether and if so upon
which stimulus p53 interacts with components of the PTPCell 149, 1536–1548, June 22, 2012 ª2012 Elsevier Inc. 1537
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Figure 1. Purified p53 Protein Opens the PTP Pore in Isolated Mitochondria Independent of Bax and Bak but Dependent on CypD
(A) In contrast to tBid, p53’s MOMP activity can also be independent of Bax and Bak. Isolated mitochondria from WT or Bax/Bak/ (DKO) MEFs were
incubated with empty elution buffer (mock), purified p53 (100 nM), or tBid (100 nM) for 30min at 30C.MOMPwas determined by release of CytoC, Smac, and AIF
into the supernatant (Sup) via immunoblotting. VDAC, loading control.
(B) p53, but not tBid opens the PTP pore independently of Bax and Bak. Mitochondria from WT or DKO MEFs were labeled with calcein-AM prior to adding
purified p53 (6.25–400 nM) or tBid (400 nM). PTP opening was measured by FACS as loss of retained mitochondrial fluorescence.
(C and D) p53 induces physical alterations of VDAC, a proposed structural PTP component. (C) p53 drives VDAC-containing complexes ranging from 60 to
300 kDa into high molecular weight complexes that no longer enter the gel. Liver mitochondria were incubated with BSA (mock) or 10, 40, and 100 nM of purified
p53 prior to chemical crosslinking and immunoblotting. Coexisting monomeric VDAC as input control. (D) p53, but not tBid, drives VDAC into high molecular
weight complexes. Analysis as in (C) with p53 and tBid proteins at 100 nM each.
(E–G) p53, but not tBid induces mitochondrial swelling in a CypD-dependent and Bax/Bak-independent manner. (E) Mitochondria isolated from Bax/Bak DKO
MEFs were incubated with buffer, 50 nM of purified p53 or tBid, or 50 mMCaCl2 for 30 min. CypD inhibitor CsA (5 mM) was added prior to proteins or CaCl2 where
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complex. Since both p53 and mPT play important roles during
oxidative stress (Gudkov and Komarova, 2010; Halestrap,
2006; Vaseva and Moll, 2009), we looked for an interaction
between p53 and the PTP components CypD, ANT, and VDAC
upon H2O2 treatment. Immunoprecipitation detected a promi-
nent oxidative stress-induced endogenous complex between
p53 and the essential regulatory PTP component CypD (Fig-
ure 2A). No interaction was seen between p53 and the pro-
posed structural components VDAC and ANT (Figure 2A). The
H2O2-inducible specific p53-CypD complex was confirmed
with pull-down assays of HA-tagged CypD, VDAC, and ANT ex-
pressed in cells with endogenous p53 (Figure 2B). Moreover,
endogenous mitochondrial p53 binds to recombinant gluta-
thione S-transferase (GST)-CypD in a CsA-dependent manner
(Figure 2C). Finally, cell-free pull-down experiments with re-
combinant proteins confirmed the direct CsA-sensitive interac-
tion (Figure 2D). Mapping experiments with a series of p53
deletionmutants identified p53 amino acids 80–220 as the region
required for CypD interaction (Figure 2E and Figures S2A–S2C).
While we failed to identify a single specific subregion, the p53
contact domains that are required for Bcl-xL/Bcl-2 interaction
(designated with ‘‘D’’) (Mihara et al., 2003) were not required
for CypD binding (Figure S2D), underlining structural differences
between the two types of interactions. Tetrameric p53 is the
preferred partner for CypD interaction (Figure 2F), while it is
debated whether mitochondrial p53 that directly triggers Bcl-2
family-mediated apoptosis at the OMM acts as monomer or
tetramer (Heyne et al., 2008; Pietsch et al., 2007).Rapid Stabilization and Mitochondrial Translocation of
p53 upon Oxidative Stress
Next, we asked whether p53 accumulates in mitochondria upon
oxidative stress. Treating various wtp53 harboring cell lines and
primaryMEFswith 0.25–0.75mMH2O2 uniformly induced robust
cellular p53 stabilization (Figure 3A). This oxidative stress-
induced p53 response was fast, reaching its peak within 1 hr in
most cells (Figure 3B). Immunofluorescence staining of C6 rat
glioma cells treated with H2O2 for 4 hr showed primarily punctate
perinuclear p53 accumulation, confirming earlier findings (Bonini
et al., 2004), which colocalized with CypD in mitochondria. This
suggests an important mitochondrial function of the p53 protein
within this window of time during oxidative stress (Figure 3C).
Moreover, using sucrose gradient ultracentrifugation, p53
accumulated in mitochondria that were free of detectable
contamination within 4 hr of H2O2 treatment (Figure 3D). Impor-
tantly, subsequent submitochondrial fractionation of this mito-
chondrial starting material (Figure S3A) confirmed that during
oxidative stress a fraction of p53 accumulated in the matrix
where CypD is located, while some also localized to the surface,
as expected (Figure 3E). The observed p53 fractions in the mito-
chondrial intermembranous space and inner membrane likely
represent transport intermediates to the matrix. Moreover,indicated. Mitochondrial swelling was measured at optical density of 540 nm. (F
pendent experiments; mean ± SD. (G) Electron microscopy images of WT or CypD
mitochondria which appear large and pale (see arrows). *Debris due to isolation
See also Figure S1.H2O2-induced mitochondrial p53 was also partially protected
from trypsin digestion in classical import assays (Figure S3B)
and import of p53 required a mitochondrial membrane potential
(Figure S3C). This is in agreement with hypoxia-induced endog-
enous complexes between p53 and the major matrix import
proteins mtHSP70 and mtHSP60 (Figure S3D), which we had
also reported earlier (Sansome et al., 2001). Of note, the endog-
enous p53 that accumulates in the mitochondrial matrix is
detectable by immunogold electron microscopy (see table in
Figure S3E).
Oxidative Stress Induces Mitochondrial Permeability
Transition in a p53-Dependent Manner
CypD-regulated mPT is a crucial event during H2O2-induced cell
death, definitively established by the CypD knockout mice. Our
initial results in isolated mitochondria had shown that purified
p53 protein was able to engage PTP in a CypD-dependent
manner (Figure 1). However, an mPT-regulatory role of p53
in vivo remained to be established. We therefore asked whether
H2O2-induced PTP opening in cells is p53 dependent.
Opening of the PTP pore and subsequent mPT results in dissi-
pation of themitochondrial membrane potentialDJmacross the
IMM. The cationic fluorescent dye tetramethylrhodamine methyl
ester (TMRM) is widely used to assess changes in DJm and
mPT. TMRM is readily sequestered by healthy mitochondria,
but its fluorescence is rapidly lost when DJm is dissipated.
Indeed, in response to H2O2 treatment WT MEFs completely
lost TMRM fluorescence. This occurred in a CypD-dependent
manner, since CypD inhibitor CsA completely blocked this event.
In contrast, p53/ MEFs remained completely unaffected
(Figures 4A–4C). Conversely, acute restoration of p53 resensi-
tizes p53 null cells to H2O2 (Figures S4A and S4B). This strong
p53-dependent response was also observed in the isogenic
HCT116 p53+/+ and p53/ pair (Figure S4C). These results
were further confirmed by direct in situ assessment of PTP
pore opening via Calcein release, which again showed p53 and
CypDdependence (seeCsA, Figures 4D and 4E and Figure S4D).
Of note, while CsA can block other cytosolic cyclophilins besides
mitochondrial matrix-specific CypD, none of them play any role
in mitochondrial mPT. In sum, the mPT-regulatory activity of
p53 in cells in response to oxidative stress is also CypD depen-
dent. In contrast, p53 does not respond to calcium overload, and
calcium overload-induced PTP opening and necrosis does not
require p53 (Figures S4E–S4H).
Oxidative Stress Induces Necrosis that Concomitantly
Depends on p53 and CypD
Both necrosis and apoptosis are oxidative stress-induced cell
death modes (Javadov and Karmazyn, 2007). Upon oxidative
stress, CypD primarily mediates necrotic death via PTP and
mPT (Baines et al., 2005; Nakagawa et al., 2005), and evidence
exists that CypD can actively suppress apoptosis (Eliseev) Mitochondria from WT or cypD/ MEFs were treated as in (E). Three inde-
/mitochondria treated as in (F). p53 induces swelling in WT but not CypD/
procedure.
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Figure 2. Mitochondrial p53 Interacts with CypD, but Not with VDAC or ANT
(A) p53 forms a prominent oxidative stress-induced endogenous complex with CypD, but not with VDAC or ANT. HCT116 p53+/+ cells were treated with 0.4 mM
H2O2 for 6 hr. Mitochondria were isolated, lysed, and immunoprecipitated with p53 antibody or IgG followed by immunoblot.
(B) CypD but not VDAC or ANT binds to p53. HCT116 p53+/+ cells expressing HA-tagged CypD, ANT, or VDACwere treated with 0.4 mMH2O2 for 6 hr, lysed, and
immunoprecipitated with anti-HA followed by immunoblot.
(C) p53 binds to CypD. Binding is blocked by the CypD inhibitor CsA. Mitochondrial lysates of HCT116 p53+/+ cells (right) treated with 5 mMCamptothecin (CMT)
for 3 hr were incubated with CypD-GST or GST alone (Coomassie) ± CsA (5 mM), washed and immunoblotted for p53.
(D) Direct interaction between recombinant p53 and CypD proteins is CsA dependent. Purified p53 and CypD-GST proteins were used in GST pull-down assays
with 5 mM CsA where indicated.
(E) Mapping the CypD interaction on p53. The indicated p53 deletion constructs were transfected into HCT116 p53/ cells. Binding was assayed with purified
CypD-GST protein. Lack () or presence (+) of binding is indicated.
(F) Tetrameric p53 is the preferred partner for CypD interaction. Purified wild-type, monomeric (KEEK, for F341K, L344E, L348E, A355K) or dimeric (L229K) p53
mutants were used in pull-down assays with purified CypD-GST.
See also Figure S2.
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Figure 3. Upon Oxidative Stress, p53 Is
Stabilized and Accumulates inMitochondria
(A and B) Robust (A) and rapid (B) stabilization of
wt p53 in cells treated with H2O2. Doses and times
as indicated. Immunoblot, PCNA loading control.
(C) Endogenous p53 accumulates in a punctate
perinuclear pattern that colocalizes with CypD. C6
rat glioma cells (wt p53) were left untreated or
treated with 0.4 mM H2O2 for 6 hr. Immunofluo-
rescence analysis.
(D) Rapid mitochondrial p53 accumulation upon
oxidative stress. Cells were treated with H2O2 for
4 hr. Mitochondrial fractions were prepared by
sucrose gradient ultracentrifugation. PCNA serves
as indicator of purity of mitochondrial fractions and
as loading control for crude and cytosolic frac-
tions. CypD serves as mitochondrial marker and
loading control for mitochondrial fractions.
(E) Upon oxidative stress, p53 accumulates in the
mitochondrial matrix. Isolated mitochondria from
HCT116 p53+/+ cells treated with 0.5 mM H2O2
for 4 hr shown in (D) were further subjected
to submitochondrial fractionation. M, crude mito-
chondrial; OM, outer membrane; IMS, intermem-
brane space; IM, inner membrane; MA, matrix.
See also Figure S3.et al., 2009; Li et al., 2004; Machida et al., 2006). On the other
hand, while p53 protein is a well-established apoptosis regu-
lator, almost nothing is known if and when p53 participates in
regulating necrotic cell death. Importantly, primary p53-deficient
MEFs were equally well protected from H2O2-induced cell death
as CypD-deficient MEFs, while 60% of WT MEFs died, as indi-
cated by cell viability assays measuring metabolic activity and
membrane integrity (Figure 5A). To determine the nature of this
cell death we first measured apoptosis. Notably, only negligible
TUNEL positivity was detected in all genotypes and H2O2 condi-
tions used (Figure 5B). Thus, upon oxidative stress the protection
of primary MEFs bestowed by loss of p53 and CypD, and
conversely the death of WT MEFs, is largely unrelated to
apoptosis. Instead, electron microscopy of H2O2-treated WT
MEFs revealed all signatures of necrosis, such as loss of plasma
membrane integrity, organelle swelling, massive intracellular
vacuoles, and lack of nuclear fragmentation (Figure 5C and Fig-
ure S5A). The same holds true for cancer cells, as shown by the
HCT116p53+/+ andp53/ colorectal carcinomapair (Figure 5D).Cell 149, 1536–154Lack of p53 or silencing of CypD by
shRNA (see Figure S5B) caused signifi-
cant resistance to H2O2-induced cell
death, while 50% of WT cells were killed.
On the other hand, a similar rescue effect
was obtained by eliminating/silencing
p53 alone or together with CypD, i.e.,
p53 was epistatic to CypD, further sup-
porting that they act on the same
biochemical pathway. Again, apoptosis
levels in HCT116 p53+/+ cells were very
low (10%), confirmed by the complete
absence of cleaved PARP induction (Fig-ure 5E), and did not account for the observed 50% of cell
death (Figure 5D). Instead, H2O2-treated cells released large
quantities of High Mobility Group Box 1 (HMGB1) protein into
the culture medium in a dose-dependent, p53-dependent, and
CypD-dependent manner (Figure 5E, right). Released HMGB1
is the classical biochemical hallmark specific for necrosis. In
contrast, in apoptotic cells HMGB1 binds irreversibly to the
condensed chromatin in the nucleus (Bianchi and Manfredi,
2004). While stabilization of p53 alone was sufficient to induce
p53 accumulation at mitochondria, it was not sufficient to induce
PTP opening in the absence of oxidative stress (Figure S5C).
In sum, these data indicated that the predominant mode of
cell death in response to H2O2 was p53/CypD-mediated
necrotic cell death. Moreover, in addition to camptothecin-
induced apoptosis (Figure 5E, left), Camptothecin also triggered
some necrosis, as indicated by HMGB1 release that was
p53 and CypD dependent (Figure S5D). This is consistent
with the observed camptothecin-induced p53-CypD complex
(Figure 2C).8, June 22, 2012 ª2012 Elsevier Inc. 1541
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Figure 4. Oxidative Stress Induces mPT and PTP Opening in a p53-Dependent Manner
(A–C) p53 deficiency renders cells resistant to H2O2-induced and CsA-dependent loss of mitochondrial membrane potential (DJm). WT and p53
/MEFs were
treated with 0.4 mM H2O2 for 8 hr ± 2 mM CsA and stained with the DJm-sensitive dye TMRM. (A) TMRM assessed by fluorescence microscopy. Protonophore
FCCP as control. (B) Mean TMRMfluorescence of three independent experiments ±SDmeasured by AxioVision Automatic Quantitation. (C). TMRMfluorescence
of MEFs treated as in (A), measured by FACS.
(D and E) p53 deficiency renders primary MEFs resistant to PTP opening. WT and p53/ MEFs were treated with 0.4 mM H2O2 for 8 hr ± 2 mM CsA. Calcein
release assay. (D) Representative images by fluorescence microscopy. (E) Mean calcein fluorescence from three independent experiments ±SD, measured by
FACS. Ionophore ionomycin as control.
See also Figure S4.
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Figure 5. Oxidative Stress Induces Necro-
sis that Concomitantly Depends on p53
and CypD
(A) p53/ and CypD/ cells are resistant to
H2O2-induced cell death. Primary MEFs of the
indicated genotypes were treated with H2O2 for
24 hr. Cell death was measured by CTB viability
(left) or trypan blue exclusion assays (right).
(B) H2O2 does not induce significant apoptosis.
Primary MEFs were treated with H2O2 for 24 hr as
in (A). Apoptosis was assessed by TUNEL assays.
(C) WT MEFs were treated with 0.5 mM H2O2 for
24 hr and the morphological hallmarks of necrotic
cell death confirmed by electron microscopy.
(D) p53 deficiency and silencing of CypD protects
cells from H2O2-induced necrosis. Cell death of
HCT116 p53+/+ versus HCT116 p53/ cells
treated with H2O2 for 24 hr in the presence of
control shRNA (luc) or two independent cypD
shRNAs. CTB viability (left) and trypan blue ex-
clusion assays (right).
(E) Absence of significant apoptosis in cells from
(D), as measured by TUNEL (left) and absence of
PARP cleavage (right). In contrast, H2O2-treated
cells release large quantities of necrosis indicator
HMGB1 into the medium in a dose-, p53-, and
CypD-dependent manner. Immunoblot.
(A)–(E) Data are mean ± SD.
See also Figure S5.Direct Targeting of p53 to the Mitochondrial Matrix
Induces mPT and Necrosis in a CypD-Dependent
Manner; Oxidative Stress-Induced PTP Opening and
Necrosis Are Largely Transcription Independent
Although the above data strongly suggest a direct necrosis-
regulating action of p53 at the mitochondria, oxidative stress
also induces p53 target genes, some of which might contribute
to regulate the observed H2O2 response in a CypD-dependent
manner. For example, proteins participating in pro- or antioxi-
dation that modulate cellular ROS levels are transcriptional
p53 targets (Hussain et al., 2004; Macip et al., 2003; Sablina
et al., 2005). Thus, direct proof was necessary to substantiate
the local action of mitochondrial p53, as opposed to its nuclear
action.
To this end we first used direct targeting of p53 to the mito-
chondrial matrix. We had previously generated various mito-Cell 149, 1536–154chondrially targeted versions of wild-
type p53 (Mihara et al., 2003). One of
them, called Lp53 (wt p53 fused to the
mitochondrial import leader sequence
of ornithine transcarbamylase) delivers
p53 specifically and exclusively to the
mitochondrial matrix, where the leader
sequence gets cleaved off (Mihara et al.,
2003) (Figure 6A left and Figure S6A).
Importantly, Lp53 completely bypasses
the nucleus and is devoid of any tran-
scriptional activities (Mihara et al., 2003).
Indeed, adenoviral delivery of Lp53 intothe mitochondrial matrix caused a major loss of DJm in WT
MEFs, indicated by loss of TMRM fluorescence. In contrast,
Lp53 had no effect in CypD/MEFs (Figure 6A right). This indi-
cates that p53 in the mitochondrial matrix can regulate PTP
opening in cells independent of p53 transcription. This direct
p53 action requires CypD. Moreover, PFTa, an inhibitor of p53-
mediated transcription, or a-amanitin, a powerful general tran-
scriptional inhibitor of RNA Polymerase II, did not significantly
prevent oxidative stress-induced PTP opening or cell death in
WT MEFs (Figure 6B and Figures S6B and S6C), confirming
the largely transcription-independent effect of p53 in this
context. Furthermore, at early time points (e.g., 12 hr) when
H2O2 had not yet killed many cells, Lp53 sensitized WT MEFs
and HCT116 p53/ cells in a CypD-dependent manner (Fig-
ure 6C and Figures S6D–S6F). Again, robust p53- and CypD-
dependent HMGB1 release into the medium (Figure 6C) and8, June 22, 2012 ª2012 Elsevier Inc. 1543
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Figure 6. Direct Targeting of p53 to Mitochondrial Matrix Induces mPT and Necrosis in a CypD-Dependent Manner, and Oxidative Stress-
Induced PTP Opening and Necrosis Is Largely Transcription Independent
(A) Mitochondrial matrix-targeted p53 (Lp53) causes collapse ofDJm inWT but not in CypD/MEFs.WT and CypD/MEFs were infected with Ad5-GFP (vect)
or Ad5-Lp53-GFP that targets p53 exclusively to themitochondrial matrix. Left, mitochondrial fractions from these cells show localization of Lp53 at mitochondria
independent of CypD. Right, 24 hr after infection TMRM was added to the medium to visualize loss of DJm.
(B) Transcriptional blockade does not prevent H2O2-induced PTP opening and necrosis. Left, loss of mitochondrial calcein indicates PTP opening after
treatment of WT MEFs with 0.5 mM H2O2 for 8 hr in the presence of a-amanitin or PFTa ± CsA. Right, survival of WT MEFs treated with H2O2 for 24 hr. CTB
viability assay.
(C and D) Mitochondrial matrix-targeted p53 (Lp53) sensitizes cells to H2O2-induced CypD-dependent necrosis. (C) Survival and HMGB1 release of WT or
CypD/MEFs (left) or HCT116 p53/ cells stably expressing luc shRNA or cypD shRNA (right) infected with vector or Lp53 (100 PFU each) after H2O2 treatment
for 12 hr. CTB assay. At this early time point, H2O2 had not yet killed many cells. (D) Only minimal apoptosis in HCT116 p53
/ cells from (C). Positive control,
infection with 400 PFU Lp53 for 48 hr. TUNEL assay.
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lack of significant apoptosis (Figure 6D) confirmed the primarily
necrotic nature of the cell death.
To further support the role of mitochondrial p53 in oxidative
stress-induced necrotic death, we used Bax/Bak DKO MEFs.
Adenovirally delivered Lp53 in Bax/Bak DKO MEFs localized to
mitochondria (Figure S6G) and importantly, bound to endoge-
nous CypD (Figure S6H). As already seen for WT MEFs (Fig-
ure 6C), Lp53 greatly sensitized DKO cells to oxidative stress
at early time points, and this sensitivity was abolished upon
CypD knockdown (Figure 6E and Figure S6I). Cell death was
again due to necrosis and not apoptosis, as indicated by
HMGB1 release that depended on the presence of CypD, as
well as the absence of Casp3 and PARP cleavage (Figure 6F
and Figure S6J). In sum, the physical interaction between mito-
chondrial p53 and CypD is critical to induce necrotic cell death
upon oxidative stress. This p53 action is independent of Bax
and Bak.
Pathologic p53-CypD Complex Formation during
Ischemic Stroke-Induced Brain Tissue Necrosis
In vivo, the parameters required for induction of mPT are fulfilled
during stroke (transient ischemia-reperfusion injury of the brain).
During brain ischemia, the absence of glucose and oxygen
causes mitochondrial dysfunction, intracellular calcium uptake
and a sharp decrease in ATP levels. Subsequent brain reperfu-
sion generates the conditions required for mPT as mitochondria
repolarize, sequester excess cytosolic calcium accumulated
during the ischemic period, and generate ROS and oxidative
stress. Cells (mainly neurons but also glia) die largely by
necrosis, although in the peripheral penumbra apoptosis also
takes place. Importantly, CypD deficiency confers significant
protection against ischemic brain injury in permanent and tran-
sient ischemic stroke models in mice (Schinzel et al., 2005).
Since our cell culture data identified a physical and functional
interaction between mitochondrial p53 and CypD that is critical
for oxidative stress-induced necrosis, we investigated the
pathophysiologic role of the PTP-regulating function of p53 in
transient ischemia/reperfusion stroke. To this end, WT, p53+/,
and WT control mice pretreated with CsA were subjected to
carefully controlled unilateral acute middle cerebral artery
occlusion (MCAO) for 1 hr, followed by 24 hr of reperfusion.
Infarct size was measured by staining coronal brain slices with
triphenyl-tetrazolium chloride (TTC), a dye that is oxidized by
intact mitochondrial dehydrogenase to yield the red product
formazan. In the infarcted area (white), mitochondria are un-
coupled and dysfunctional and no longer stain with TTC. WT
brains (n = 8) were grossly infarcted. Intriguingly, p53+/ brains
(n = 8) were strongly protected from stroke, similar to WT control
mice protected by intraperitoneal injection of CsA 15 min prior
to MCAO (n = 6) (Figures 7A and 7B). Most importantly, a patho-(E and F) As shown by early time points, Lp53 sensitizes Bax/Bak DKOMEFs to H2
shRNA or cypD shRNA were infected with adenoviral Lp53 or vector and treated w
of cells from (E). (B)–(E) Data are mean ± SD.
(F) Strong release of cellular HMGB1 into the medium depends on the presence of
and caspase-3 cleavage is absent. Bax/Bak DKO MEFs treated for 12 hr as in (E
caspase-3 cleavage. Immunoblot.
See also Figure S6.logic p53-CypD complex was robustly induced in infarcted
WT brains after MCAO, as shown by coimmunoprecipitation
with a specific p53 antibody but not with IgG (Figure 7C,
‘MCAO’). Intriguingly, the induced p53-CypD complex was
undetectable in CsA-pretreated, stroke-protected WT control
mice. Moreover, the complex was only barely detectable in
p53+/ mice, whose stroke stress-mediated p53 induction did
not exceed the baseline p53 levels of WT control mice, and
which were also strongly protected from infarction (Figure 7C).
Thus, a strong association exists between the formation of
the pathologic p53-cypD complex and ischemia-reperfusion
brain infarction. These data support the idea that this p53-
CypD axis is an important pathophysiologic contributor to
ischemic stroke.
DISCUSSION
Here, we identify a new role of p53 in activating necrotic cell
death. In response to oxidative stress and ischemia, p53 protein
accumulates in the mitochondrial matrix and triggers PTP
opening, mPT and necrosis by physical interaction with the crit-
ical PTP regulator CypD. This p53 action is transcription-inde-
pendent and inhibited by the specific CypD inhibitor CsA, and
by genetic CypD deletion or knockdown. In support, in contrast
to the prototypical MOMP-inducer tBid, purified p53 protein has
efficacy that goes beyond activating the Bax/Bak lipid pore at
the outer membrane. p53 is able to also rapidly open the PTP
pore at the inner membrane in healthy Bax/Bak/ mitochon-
dria where tBid fails. Similarly, p53 causes structural alterations
of the PTP pore, while tBid does not. Using gene knockout and
knockdown in mouse and human cells, we show that oxidative
stress induces PTP opening, mPT and necrosis that concomi-
tantly depend on the presence of p53 and CypD. Importantly,
WT, Bax/Bak DKO and p53/ cells are all (further) sensitized
to H2O2-induced PTP opening and necrotic death upon direct
delivery of p53 into the mitochondrial matrix. This sensitivity is
reversed by knockdown of CypD, confirming the physiological
p53-CypD crosstalk. Most intriguingly, a robust p53-CypD
complex is formed during necrosis in brain tissue upon
ischemia/reperfusion stroke injury. In contrast, genetic reduction
of p53 levels (p53+/ mice) or CsA pretreatment of WT mice
prevents this complex from forming, and is associated with
effective stroke protection. This strongly supports a pathophysi-
ologic role of the mitochondrial p53-CypD axis in ischemic
stroke.
Aside from p53, very few extramitochondrial proteins are
known to bind CypD and trigger pathologic PTP opening.
A compelling analogy to p53, albeit acting chronically, is the
highly toxic, soluble intracellular form of b amyloid peptide
(Ab), a key protein in Alzheimer’s disease (AD) that progressivelyO2 in a CypD-dependent manner. (E) Bax/Bak DKOMEFs stably expressing luc
ith H2O2 for 12 hr. Cell viability measured as above. Bottom, bright-field image
both Lp53 and H2O2. This effect is reversed by downregulation of CypD. PARP
). WT MEFs treated with Camptothecin serve as positive control for PARP and
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Figure 7. The p53-CypD Complex Has
a Pathophysiologic Role in Ischemic Stroke
(A–C) Ischemia/reperfusion-mediated brain injury.
Littermates (6- to 8-week-old males) of WT,
heterozygous p53+/ and WT control mice pre-
treated with CsA (15 mg/kg i.p., 15 min prior to
MCAO) were subjected to middle cerebral artery
occlusion (MCAO, right side) for 1 hr followed by
reperfusion for 24 hr under cerebral blood flow and
temperature-controlled conditions. Control mice
(‘‘no MCAO’’) underwent all steps of the surgery
without blockade of the MCA. (A) Representative
TTC-stained coronal brain sections; white indi-
cates infarcted tissue. The number of mice is
indicated. (B) Mean infarct size ±SD. In contrast to
infarctedWT brains (n = 8), p53+/ brains (n = 8) are
strongly stroke-protected and phenocopy the
brain protection seen in cyclosporine A-pretreated
WT mice (n = 6). (C) In both cases, stroke protec-
tion directly correlates with the absence of an
ischemia-induced p53-CypD complex in brain
tissue. Coimmunoprecipitation with p53 antibody
or nonspecific IgG from the 25 hr necrotic
(MCAO) or corresponding contralateral control
hemispheres from representative brains treated
as in (A). Immunoblotting for CypD. Input shown.
See also Figure S7.accumulates in brain mitochondria of AD patients and AD trans-
genic mice. In AD, Ab forms a critical complex with CypD that
promotes PTP opening, thereby boosting Ca2+-induced mito-
chondrial damage and neuronal injury. Inhibiting PTP or ablating
CypD in AD mice renders their cortical brain mitochondria resis-
tant to PTP opening and improves their cognitive functions (Du
et al., 2008).
In response to many insults, a continuum of apoptosis and
necrosis exists. Such insults induce apoptosis at lower doses
and necrosis at higher doses, a scenario that is clearly the
case in ischemic brain infarction with an apoptotic penumbra
surrounding a necrotic center (Zong and Thompson, 2006).
The long-standing paradigm had been that p53 controls
apoptosis but plays no role in necrosis. Only recently the very
first link between p53 and necrosis was reported. Upon
etoposide-mediated DNA damage Bax/Bak DKO MEFs die via
slow necrosis, which is largely controlled by p53-mediated tran-
scription of cathepsin Q in cooperation with DNA damage-
induced ROS (Tu et al., 2009). Interestingly, however, this tran-
scriptional p53-cathepsin Q axis only plays a minor role in the
corresponding WT MEF necrosis. In contrast, H2O2-induced
necrosis in DKO MEFs was found to be completely transcription
independent (Tu et al., 2009), supporting our finding of direct
CypD-mediated necrotic signaling by p53. Thus, in response to
oxidative stress our data establish a necrotic mitochondrial
p53 program, in addition to the well-characterized mitochon-
drion-based apoptotic p53 program. The decision of whether
to engage one and/or the other appears to depend on the type
and dose of stress. Clearly though, necrotic signaling also uses
p53-independent pathways, depending on the insult. Examples
are necrosis induced by DNA alkylating agents which signals
through PARP and necrosis signaling via the TNFR/RIP1
pathway (Zong and Thompson, 2006).1546 Cell 149, 1536–1548, June 22, 2012 ª2012 Elsevier Inc.In oxidative damage, our data show that p53 can control
a CypD-mediated necrotic program in various cell types in vitro
and in brain tissue in vivo. The surprisingly strong brain protec-
tion of p53+/ mice from ischemia/reperfusion injury (Figures
7A and 7B) is likely due to two components: The absence of
a destructive p53-CypD complex, thereby protecting the PTP
pore (Figure 7C), and the presence of an only weak p53
apoptosis program such as e.g., Puma and Noxa (Figure S7A).
Importantly though, the absence of the p53-CypD complex
appears to be the dominant factor in stroke protection. This is
indicated by CsA-protected WT brains that do not form the
p53-CypD complex, yet concomitantly mount a full-blown p53
apoptosis program including Puma and Noxa (Figure S7A).
Conversely, p53/ MEFs but not Puma/MEFs are protected
from oxidative stress-induced cell death, confirming that Puma
does not play a significant role in this process (Figure S7B).
Parenthetically, the p53 homolog p73, which is robustly ex-
pressed in adult mouse and human brain, was not induced in
the ischemic brain tissues (Figure S7C). Finally, although low or
uninduced levels of p53 can clearly mount a transcriptional anti-
oxidant defense by regulating expression of, e.g., sestrins, gluta-
thione peroxidase and TIGAR, this is highly tissue specific.
Notably, in brain tissue p53 is constitutively pro-oxidant in both
physiologic and pathologic conditions due to transcriptional
repression of antioxidant genes (Chatoo et al., 2009). Thus,
a protective p53 antioxidant program is likely not a factor in the
observed p53+/ stroke protection. Interestingly, for reasons
that are currently not clear, p53/ brains were not as protected
as p53+/ brains (data not shown), consistent with a previous
report (Crumrine et al., 1994).
CypD/mice show strong protection against focal ischemia-
reperfusion brain injury (Schinzel et al., 2005). Similarly, mice and
rats treated with CsA or nonimmunosuppressive derivatives
that do not bind to calcineurin are also protected from stroke
(Khaspekov et al., 1999; Korde et al., 2007; Matsumoto et al.,
1999). Clinically, CsA is chronically given to organ transplant
patients as a time-tested immunosuppressant. Our data suggest
that acute temporary blockade of the destructive p53-CypD
complex by CsA-type inhibitors may be a therapeutic strategy
to limit infarct extent in the rising number of ischemic stroke
patients where reperfusion of the occluded artery can be
reestablished by interventional thrombolysis.
EXPERIMENTAL PROCEDURES
Cell Culture
Primary WT and p53/ mouse embryo fibroblasts (MEFs) were established
from E13.5 embryos. Primary CypD/MEFs were purchased (ArtisOptimus).
Bax/Bak DKO and corresponding WT MEFs were a gift of Dr. Weixing Zong,
Stony Brook Univ. MEFs (all SV40 immortalized) and cancer cell lines
were maintained in DMEM/10% FBS. Cyclosporine A, a-amanitin, Pifithrin-a,
ionomycin, and FCCP were purchased from Sigma.
Plasmids and Recombinant Proteins
pGEX-CypD were a gift from Dr. Dario Altieri, University of Massachusetts
(Kang et al., 2007). Human cypD, ANT-2 and VDAC-1 cDNAs in pHA vectors
were gifts from Dr. Stefan Grimm, Max-Planck-Institute, Germany (Bauer
et al., 1999). Immunoaffinity purified recombinant human p53 expressed in
human cells was purchased (Origene). Recombinant adenovirus (Ad5-GFP)
was generated as described previously (Palacios et al., 2008) under the control
of a CMV promoter. Luc shRNA and CypD shRNA plasmids were purchased
(Dharmacon).
Mitochondrial Isolation
Mitochondria from cultured cells and mouse liver were isolated by sucrose
gradients aswe described (Mihara et al., 2003).Mitochondria (35 mg) were sub-
jected to chemical crosslinking with BMH (1,6-bis-maleimidohexane, Pierce,
10 mM in dimethyl sulfoxide [DMSO] for 10 min) or mock treated (DMSO
only). Submitochondrial fractionation was performed by phosphate swelling-
shrinking as described (Kang et al., 2007) and detailed in the Supplemental
Information. For mitochondrial assays, see also Supplemental Information.
Biochemical Assays
For immunoprecipitation, isolated mitochondria or cells were lysed in PBS
containing 1% Triton X-100 and protease inhibitors (Roche). After centrifuga-
tion at 13,000 3 g for 10 min at 4C, the supernatant was precleared with
Protein G-agarose beads (Roche) for 2 hr at 4C, and 500 mg of precleared
protein extracts were incubated with antibody to p53 or CypD for 16 hr at
4C. Precipitated complexes were washed in lysis buffer and bound proteins
analyzed by immunoblots. For GST pull-down experiments, bead -bound
GST-CypD was blocked with H-buffer (20 mM HEPES pH 7.7, 75 mM KCl,
0.1 mM EDTA, 2.5 mM MgCl2, 0.05% NP40, 1 mM DTT, 1 mg/ml BSA).
Blocked beads were incubated with cell/mitochondria lysates or recombinant
proteins for 16 hr at 4C in the presence of 5 mMCsA or vehicle. Pelleted beads
were washed in H-buffer and bound proteins analyzed by immunoblots. For
HA-pull down assays, HA-antibody (Abcam) was used to precipitate protein
complexes from cells expressing HA-tagged CypD, VDAC or ANT.
Cell Death Assays
Cell viability was assessed by Cell Titer Blue (CTB) and Trypan Blue Exclusion
assays (Sigma). Apoptosis was measured by TUNEL (TMR Red Kit, Roche).
Nuclei were counterstained with Hoechst 33342. Apoptosis was quantified
as the proportion of red/blue areas from three representative images (Zeiss
Axioskope with AxioVision v4.3).
HMGB1 Release Assay
Medium from treated cells was harvested, spun at 8003 g for 5min and super-
natant filtered (0.45 mm). Proteins were precipitated with trichloroacetic acid
and analyzed by HMGB1 immunoblots.Transient Focal Cerebral Ischemia—MCAO
Male 6- to 8-week-old littermate WT and p53+/ (Sv129) were used for all
experiments. Focal cerebral ischemia was induced in anesthetized mice by
inserting an intraluminal filament in the middle cerebral artery for 60 min, fol-
lowed by 24 hr of reperfusion. During the course of the experiment blood
flow and body temperature of the animals were monitored by an experienced
investigator (K.J.) who was naive to the genetic identity of individual mice.
Mock-injured animals were kept under the same conditions. Where indicated,
cyclosporine A (15mg/kg) was administered 15min prior toMCAO by intraper-
itoneal injection. All animal work was done in accordance with Stony Brook
University IACUC.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at doi:10.1016/j.cell.
2012.05.014.
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